Ver label

Ver

Ver Recall

Get an alert when a recall is issued.

Side Effects & Adverse Reactions

Do not use

in a child who is taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric, or emotional conditions, or Parkinson’s disease), or for 2 weeks after stopping the MAOI drug. If you do not know if your child’s prescription drug contains an MAOI, ask a doctor or pharmacist before giving this product.

Ask a doctor before use if the child has

•

heart disease

•

high blood pressure

•

thyroid disease

•

diabetes

•

cough that occurs with too much phlegm (mucus)

•

persistent or chronic cough such as occurs with asthma

When using this product

 

do not use more than directed

Stop use and ask a doctor if

•

your child gets nervous, dizzy or sleepless

•

symptoms do not get better within 7 days or occur with fever

•

cough lasts more than 7 days, comes back, or occurs with fever, rash, or persistent headache.

These could be signs of a serious condition.

Do not use

in a child who is taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric, or emotional conditions, or Parkinson’s disease), or for 2 weeks after stopping the MAOI drug. If you do not know if your child’s prescription drug contains an MAOI, ask a doctor or pharmacist before giving this product.

Ask a doctor before use if the child has

•

heart disease

•

high blood pressure

•

thyroid disease

•

diabetes

•

cough that occurs with too much phlegm (mucus)

•

persistent or chronic cough such as occurs with asthma

Stop use and ask a doctor if

•

your child gets nervous, dizzy or sleepless

•

symptoms do not get better within 7 days or occur with fever

•

cough lasts more than 7 days, comes back, or occurs with fever, rash, or persistent headache.

These could be signs of a serious condition.

FDA Safety Alerts

There are currently no FDA safety alerts available for this drug.

Manufacturer Warnings

There is currently no manufacturer warning information available for this drug.

FDA Labeling Changes

There are currently no FDA labeling changes available for this drug.

Uses

•

helps loosen phlegm (mucus) and thin bronchial secretions to rid the bronchial passageways of bothersome mucus and make coughs more productive

•

temporarily relieves:

•

cough due to minor throat and bronchial irritation as may occur with the common cold or inhaled irritants

•

the intensity of coughing

•

the impulse to cough to help your child get to sleep

•

nasal congestion due to a cold

•

stuffy nose

History

There is currently no drug history available for this drug.

Other Information

There are no additional details available for this product.

Ver Manufacturers

  • Deseret Biologicals, Inc.
    Ver | Dolgencorp Inc
    No Recall

    Ver | Dolgencorp Inc

    Ver | Dolgencorp Inc
    • do not take more than 6 doses in any 24-hour period • measure only with dosing cup provided • do not use dosing cup with other products • dose as follows or as directed by a doctor • mL = milliliter

    Age

    Dose

    children 6 years to under 12 years

    10 mL every 4 hours

    children 4 years to under 6 years

    5 mL every 4 hours

    children under 4 years

    do not use

    Other information • each 5 mL contains: sodium 3 mg • do not use if printed neckband is broken or missing • store at 20-25 °C (68-77 °F) • do not refrigerate • dosing cup provided
  • Deseret Biologicals, Inc.
    Ver | American Health Packaging
    No Recall

    Ver | American Health Packaging

    Ver | American Health Packaging

    Appetite Stimulation: Initially, 2.5 mg dronabinol capsules should be administered orally twice daily (b.i.d.), before lunch and supper. For patients unable to tolerate this 5 mg/day dosage of dronabinol capsules, the dosage can be reduced to 2.5 mg/day, administered as a single dose in the evening or at bedtime. If clinically indicated and in the absence of significant adverse effects, the dosage may be gradually increased to a maximum of 20 mg/day dronabinol capsules, administered in divided oral doses. Caution should be exercised in escalating the dosage of dronabinol capsules because of the increased frequency of dose-related adverse experiences at higher dosages. (See PRECAUTIONS)

    Antiemetic: Dronabinol Capsules are best administered at an initial dose of 5 mg/m2, given 1 to 3 hours prior to the administration of chemotherapy, then every 2 to 4 hours after chemotherapy is given, for a total of 4 to 6 doses/day. Should the 5 mg/m2 dose prove to be ineffective, and in the absence of significant side effects, the dose may be escalated by 2.5 mg/m2 increments to a maximum of 15 mg/m2 per dose. Caution should be exercised in dose escalation, however, as the incidence of disturbing psychiatric symptoms increases significantly at maximum dose (see PRECAUTIONS).

  • Ver | Apotheca Company
    No Recall

    Ver | Apotheca Company

    Ver | Apotheca Company

    DIRECTIONS:  1-10 drops under the tongue, 3 times a day or as directed by a health professional.  Consult a physician for use in children under 12 years of age.

  • Deseret Biologicals, Inc.
    Ver | Equaline (supervalu)
    No Recall

    Ver | Equaline (supervalu)

    Ver | Equaline (supervalu)
    take with a glass of water  adults and children 12 years and over  take 1 to 3 softgels daily. This dose may be taken as a single daily dose or in divided doses.   children 2 to under 12 years of age   take 1 softgel daily   children under 2 years  ask a doctor